Home > About > News > Archived News

Archived News

pdf icon2021-04-26 OSE Immunotherapeutics and Veloxis Pharmaceuticals Enter Into

pdf icon2020-06-18 Transplant Therapeutics Consortium Receives

pdf icon2019-05-31 Envarsus XR to be Subject of Upcoming Presentations at 2019 American Transplant Congress

pdf icon2018-12-19 FDA Approves New Indication for ENVARSUS XR (tacrolimus extended-release tablets)

pdf icon2018-06-04 Veloxis Partners with the American Society of Transplant Surgeons to Award First Annual

pdf icon2018-04-19 FDA Accepts Veloxis's Supplemental New Drug Application for the De Novo Indication for ENVARSUS

pdf icon2018-03-28 Veloxis Announces the Publication of ASERTAA A Study of Extended Release Tacrolimus

pdf icon2018-03-07 Veloxis Files with FDA for the De Novo Indication for ENVARSUS XR

pdf icon2017-09-13 Veloxis Pharmaceuticals, Inc., Appoints Ulf Meier-Kriesche, MD, as Chief Scientific Officer

pdf icon2017-06-06 Veloxis Pharmaceuticals AS Announces Agreement with Chiesi Farmaceutici SpA to Commercialize